Data / Drug companies / Loratadine, pseudoephedrine sulfate
Loratadine, pseudoephedrine sulfate: 15 companies and 21 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Loratadine, pseudoephedrine sulfate is listed in the FDA National Drug Code Directory by 15 companies, with 21 products in commercial distribution. 21 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated, extended release; tablet, extended release, and the newest product started marketing on October 3, 2025.
The request: Get every company that lists loratadine, pseudoephedrine sulfate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 15
- Products
- 21
- Generic (ANDA) products
- 21 (100.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Allergy Relief D, Topcare Allergy and Congestion Relief, Allergy Relief D 12, Loratadine D, Signature Care Allergy and Congestion Relief, Perrigo Allergy D, Allergy and Nasal Congestion, Equate Allergy and Congestion Relief
- openFDA record search
- api.fda.gov
Companies that list loratadine, pseudoephedrine sulfate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| L. Perrigo Company | 3 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | October 3, 2025 |
| Costco Wholesale Company | 2 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | October 3, 2025 |
| Kroger Company | 2 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | February 22, 2024 |
| Topco Associates LLC | 2 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | August 16, 2023 |
| Walgreen Company | 2 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | February 7, 2024 |
| Amerisource Bergen | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | April 23, 2018 |
| CVS Pharmacy | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | April 19, 2018 |
| Cardinal Health 110, LLC. DBA Leader | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | January 9, 2020 |
| Meijer Distribution Inc | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | June 12, 2018 |
| Padagis Israel Pharmaceuticals Ltd | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | April 10, 2018 |
| Publix Super Markets Inc | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | April 23, 2018 |
| Safeway | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | April 2, 2018 |
| Sportpharm LLC | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | April 10, 2018 |
| Strategic Sourcing Services LLC | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | October 19, 2023 |
| Wal-Mart Stores Inc | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | July 24, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated, extended release | 16 | 76.2% |
| Tablet, extended release | 5 | 23.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 21 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| alpha-Adrenergic Agonist | 21 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.